"Sialorrhea" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increased salivary flow.
Descriptor ID |
D012798
|
MeSH Number(s) |
C07.465.815.815
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sialorrhea".
Below are MeSH descriptors whose meaning is more specific than "Sialorrhea".
This graph shows the total number of publications written about "Sialorrhea" by people in this website by year, and whether "Sialorrhea" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2007 | 1 | 1 | 2 |
2008 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sialorrhea" by people in Profiles.
-
Comparing botulinum toxin and 4-duct ligation for Sialorrhea in children - A systematic review. Am J Otolaryngol. 2024 Mar-Apr; 45(2):104119.
-
Comprehensive management of anterior drooling: An International Pediatric Otolaryngology Group (IPOG) consensus statement. Int J Pediatr Otorhinolaryngol. 2023 May; 168:111500.
-
Drooling and Aspiration of Saliva. Otolaryngol Clin North Am. 2022 Dec; 55(6):1181-1194.
-
Severity of sialorrhea and tracheal secretions in infants and toddlers with a tracheostomy with a focus on quality of life. Am J Otolaryngol. 2021 Nov-Dec; 42(6):103074.
-
Comparing methods to collect saliva from children to analyze cytokines related to allergic inflammation. Ann Allergy Asthma Immunol. 2015 Jan; 114(1):63-4.
-
Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders. Toxicon. 2013 Jun 01; 67:141-52.
-
Immediate-release oxybutynin for the treatment of clozapine-induced sialorrhea. Ann Pharmacother. 2011 Sep; 45(9):e45.
-
Treatment of dysautonomia associated with Parkinson's disease. Parkinsonism Relat Disord. 2009 Dec; 15 Suppl 3:S224-32.
-
Disease-oriented approach to botulinum toxin use. Toxicon. 2009 Oct; 54(5):614-23.
-
Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease. Expert Rev Neurother. 2007 Jun; 7(6):637-47.